Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

HealthAge · Joint Training and Research Program on Lifespan Regulation Mechanisms in Health and Disease

H2020Status: CLOSED1 May 201931 December 2023EU funding €3,940,624Call H2020-MSCA-ITN-2018

Aging is an inexorable homeostatic failure of complex but largely unknown aetiology that leads to increased vulnerability to disease with enormous consequences on the quality of individual lives and the overall cost to society. Although, aging is driven by limitations in somatic maintenance, it is also subject to regulation by evolutionarily highly conserved molecular pathways. Indeed, macromolecular damage may drive the functional decline with aging; however, a battery of conserved, longevity assurance mechanisms may set the pace on how rapidly damage builds up and function is lost over time. Human efforts over the last centuries have succeeded in substantially lengthening lifespan, allowing aging to become a common feature of western societies. However, The discouraging complexity of the aging process, the noticeable lack of tools to study it, and a shortage of experimentally tractable model systems have made it significantly challenging to unravel the molecular basis of the processes that cause loss of bodily functions and degeneration of cells and tissues with advancing age. HealthAge was carefully designed to create a joint European program of excellence in training and research with a core intellectual focus on the functional role of “Lifespan Regulation Mechanisms in Health and Disease”. To tackle this, HealthAge combines top-level, state-of-the-art and interdisciplinary research skills that range from basic molecular mechanisms and ‘omics’ level understanding to translational research and clinical applications. This interdisciplinary strategy will allow us to gain functional insight into the fundamental mechanisms regulating longevity as well as to develop a series of rationalized intervention strategies aimed at counteracting age-related diseases.

Consortium · 20 organisations

coordinator

IDRYMA TECHNOLOGIAS KAI EREVNAS

EL · €486,035

partner

ETAIRIA DIACHIRISIS KAI ANAPTIXIS EPISTIMONIKOU KAI TECHNOLOGIKOU PARKOU KRITIS AE

EL

partner

PANEPISTIMIO KRITIS

EL

partner

SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI DI TRIESTE

IT

participant

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

CH · €281,277

participant

UNIVERSITA DEGLI STUDI DI PADOVA

IT · €261,500

partner

UNIVERSITAT ZU KOLN

DE

participant

FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)

ES · €250,905

participant

PROTAVIO MONOPROSOPI E.P.E

EL · €243,018

participant

LXREPAIR

FR · €274,802

participant

TEL AVIV UNIVERSITY

IL · €263,501

participant

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

FR · €274,802

participant

AMAZENTIS SA

CH

participant

KLINIKUM DER UNIVERSITAET ZU KOELN

DE · €252,788

participant

UNIVERSITE DE LAUSANNE

CH · €243,018

partner

UNIVERSITE DE GENEVE

CH

participant

UNIVERSITAT BASEL

CH · €281,277

participant

GENEVIA TECHNOLOGIES OY

FI · €280,806

participant

NAGI BIOSCIENCE SA

CH · €281,277

participant

ACADEMISCH ZIEKENHUIS GRONINGEN

NL · €265,620

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.